Exelixis Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Exelixis Stock Summary

Exelixis competes with TG Therapeutics, Viking Therapeutics, Madrigal Pharmaceuticals, BioXcel Therapeutics, and Biomarin Pharmaceutical. Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California. Exelixis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 954 people.

Exelixis Key Financial Ratios

Exelixis Key Balance Sheet Accounts

Exelixis Key Income Statement Accounts

Exelixis Key Cash Accounts

Exelixis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Exelixis's current stock value. Our valuation model uses many indicators to compare Exelixis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exelixis competition to find correlations between indicators driving Exelixis's intrinsic value. More Info.Exelixis is rated # 3 in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about  0.63  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Exelixis is roughly  1.58 . At this time, Exelixis' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Exelixis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Exelixis Systematic Risk

Today, most investors in Exelixis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Exelixis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Exelixis growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Exelixis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Exelixis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Exelixis based on widely used predictive technical indicators. In general, we focus on analyzing Exelixis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Exelixis's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.